Van Berkom & Associates Inc. Sells 61,435 Shares of Silicon Laboratories Inc. (NASDAQ:SLAB)

Van Berkom & Associates Inc. cut its stake in Silicon Laboratories Inc. (NASDAQ:SLAB) by 9.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 557,197 shares of the semiconductor company’s stock after selling 61,435 shares during the quarter. Silicon Laboratories accounts for about 2.1% of Van Berkom & Associates Inc.’s investment portfolio, making the stock its 29th largest holding. Van Berkom & Associates Inc.’s holdings in Silicon Laboratories were worth $69,215,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in SLAB. Creative Planning lifted its position in Silicon Laboratories by 116.0% during the third quarter. Creative Planning now owns 7,985 shares of the semiconductor company’s stock valued at $923,000 after purchasing an additional 4,289 shares during the period. Raymond James & Associates raised its stake in Silicon Laboratories by 4.1% during the 3rd quarter. Raymond James & Associates now owns 65,623 shares of the semiconductor company’s stock valued at $7,584,000 after buying an additional 2,561 shares during the last quarter. International Assets Investment Management LLC lifted its holdings in shares of Silicon Laboratories by 11,457.1% during the 3rd quarter. International Assets Investment Management LLC now owns 809 shares of the semiconductor company’s stock valued at $93,000 after buying an additional 802 shares during the period. Mount Yale Investment Advisors LLC purchased a new position in shares of Silicon Laboratories in the 3rd quarter worth $208,000. Finally, Schwartz Investment Counsel Inc. boosted its stake in shares of Silicon Laboratories by 17.9% in the 3rd quarter. Schwartz Investment Counsel Inc. now owns 230,000 shares of the semiconductor company’s stock worth $26,581,000 after buying an additional 35,000 shares during the last quarter.

Insider Buying and Selling

In other Silicon Laboratories news, Director Navdeep S. Sooch sold 2,360 shares of Silicon Laboratories stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total value of $351,640.00. Following the sale, the director now directly owns 400,567 shares in the company, valued at approximately $59,684,483. The trade was a 0.59 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director William G. Bock sold 1,000 shares of the business’s stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $149.43, for a total transaction of $149,430.00. Following the completion of the sale, the director now owns 31,115 shares in the company, valued at approximately $4,649,514.45. The trade was a 3.11 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 5,360 shares of company stock valued at $782,610. Corporate insiders own 1.72% of the company’s stock.

Silicon Laboratories Stock Performance

SLAB opened at $158.70 on Friday. The firm’s fifty day moving average is $135.60 and its 200 day moving average is $119.37. Silicon Laboratories Inc. has a fifty-two week low of $94.00 and a fifty-two week high of $158.76.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, meeting analysts’ consensus estimates of ($0.11). The business had revenue of $166.25 million for the quarter, compared to analysts’ expectations of $166.09 million. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The business’s quarterly revenue was up 91.4% on a year-over-year basis. During the same period last year, the firm earned ($1.19) earnings per share. Equities analysts forecast that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently commented on the company. StockNews.com cut Silicon Laboratories from a “hold” rating to a “sell” rating in a research report on Friday, February 14th. KeyCorp upped their price target on shares of Silicon Laboratories from $115.00 to $160.00 and gave the company an “overweight” rating in a research report on Wednesday, January 22nd. Barclays raised their price objective on shares of Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a report on Friday, January 17th. Stifel Nicolaus upped their target price on shares of Silicon Laboratories from $135.00 to $145.00 and gave the company a “buy” rating in a report on Monday, January 6th. Finally, Susquehanna started coverage on shares of Silicon Laboratories in a research report on Tuesday, December 17th. They issued a “neutral” rating and a $130.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $136.20.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.